Eli Lilly LLY Net product revenue — Revenue

Similar metrics at other companies

GCTProduct revenues — Revenue

$290.82M+28.9%

NINEProduct revenues — Revenue

$45.59M+23.1%

SNDXNet Product Revenues — Revenue

$31.21M+1,526%

KOPNNet Product Revenues — Revenue

$5.42M-41.2%

ITRIProduct revenues — Revenue

$453.46M-12.3%

ACOGProduct Net — Revenue

$3.5M+910%

FAQ

What is Eli Lilly's net product revenue — revenue?

Eli Lilly (LLY) reported net product revenue — revenue of $21.4B in Q2 2026.

How has Eli Lilly's net product revenue — revenue changed year-over-year?

Eli Lilly's net product revenue — revenue increased by 45.3% year-over-year, from $14.73B to $21.4B.

What is the long-term trend for Eli Lilly's net product revenue — revenue?

Over 4 years (2021 to 2025), Eli Lilly's net product revenue — revenue has grown at a 23.8% compound annual growth rate (CAGR), from $25.96B to $60.96B.

What does net product revenue — revenue mean?

This metric represents the total gross sales of pharmaceutical products generated by the company after accounting for returns, rebates, and discounts. It serves as the primary indicator of the company's commercial success in its core therapeutic areas, including cardiometabolic, oncology, and immunology portfolios. This figure reflects the market demand for the company's proprietary drug pipeline and the effectiveness of its global distribution strategy.